To achieve this, they stably transfected MSCs with a retroviral vector expressing thymidine kinase of the herpes simplex virus (HSV-Tk) under the control of a CCL5/RANTES promoter and delivered it intravenously to an orthotopic pancreatic tumor model. This evidence concerns the gene CCL5 and pancreatic neoplasm.